| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.53B | +4.7% |
| Cost of Revenue | $1.23B | +1.4% |
| Gross Profit | $1.31B | +7.9% |
| R&D Expense | $235.9M | +6.8% |
| SG&A Expense | $607.4M | +8.2% |
| Operating Income | $432.7M | +4.7% |
| Interest Expense | $16.1M | +12.6% |
| Pre-tax Income | $413.9M | +5.2% |
| Income Tax | $116.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $645.5M | -39.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $472.7M | +13.4% |
| Inventory | $800.1M | +12.7% |
| Current Assets | $2.11B | -14.5% |
| Total Assets | $3.61B | -1.0% |
| Current Liabilities | $914.3M | -2.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $274.4M | -2.8% |
| Capital Expenditures | $129.2M | +40.4% |
| Investing Cash Flow | -$251.6M | -30.8% |
| Financing Cash Flow | -$415.3M | -230.3% |
| Free Cash Flow | $145.2M | -23.7% |
| +3.0% |
| Net Income | $296.6M | +7.0% |
| EPS (Basic) | $2.00 | +9.3% |
| EPS (Diluted) | $1.99 | +9.9% |
| Long-term Debt |
| $1.22B |
| -8.6% |
| Stockholders' Equity | $1.11B | +4.0% |